Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionAntipsychotic targeting the serotonin (5-HT1A) receptor and the trace amine-associated receptor 1 (TAAR1) receptor
Molecular Target Serotonin (5-HT1A) receptor ; Trace amine-associated receptor 1 (TAAR1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today